Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2006-09-30
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oral Intake During Labor
NCT03276741
Study of Ultrasound Imaging to Predict Time and Outcome in Pregnancies With Induced Labor
NCT00465998
The Labour Progression Study, a Cluster Randomised Trial on Labour Progression for First Time Mothers
NCT02221427
Post Term Pregnancy - Induction of Labor or Monitoring of Pregnancy
NCT00385229
The Proactive Support of Labor Study
NCT03056313
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Energy-containing soft drink
Commercial energy/sports drink
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Signs of fetal pathology:
* Different or abnormal (pathological) CTG test performed just before start of the test
* Abnormal Doppler registrations (PI in the arteria umbilicae \> 2SD for the gestational age)
* Established notch in the arteria uterinae or notch bilaterally or PI \> 2SD \> 24 weeks
* Diverging in the weight of the fetus \> - 22% or diverging in the growth of the fetus - 10% or more, and established structural pathology in the fetus, oligohydramnion (amniotic fluid index \< 6)
* Maternal diseases and pregnancy complications
* diabetes in pregnancy
* high blood pressure
* cardiovascular diseases
* rheumatic disease
* epilepsia
* lung disease, etc.
CTG test: cardiotocographic test (a measure of fetal activity)
PI: pulsatory index (velocity pattern)
SD: standard deviation
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oslo
OTHER
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rikshospitalet University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tore Henriksen, MD
Role: PRINCIPAL_INVESTIGATOR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kristin Kardel
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REK-SØR: S-05308
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.